Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
CRA International Inc (CRAI - Analyst Report) reported net loss of $53.5 million or $5.33 per share in fourth quarter 2012 versus net income of $4.4 million or 42 cents per share in the year-ago quarter. Non-GAAP net income for the reported quarter was 43 cents per share compared with 40 cents in the year-earlier quarter. Non-GAAP earnings beat the Zacks Consensus Estimate of 36 cents.
For full year 2012, net loss was $5.21 per share versus net income of $1.57 in the previous year. Non-GAAP net income for 2012 was 98 cents per share compared with $1.60 in 2011. Non-GAAP net income per share for the year missed the Zacks Consensus Estimate of $1.38.
Quarter Highlights
Revenue for fourth quarter 2012 was $67.5 million compared with $75.0 million in the year-ago quarter. The quarterly revenues beat the Zacks Consensus Estimate of $64 million. For full year 2012, revenue stood at $270.4 million compared with $305.2 million in the preceding year.
The company’s core business, Litigation and Regulatory business, continued to deliver better results, despite the general industry setbacks, backed by growth in North America and Europe. Solid performance was also registered by Intellectual Property and Labor & Employment practices. Additionally, demand for the Management Consulting businesses also improved in the reported quarter.
CRA international witnessed a non-GAAP operating margin of 10% in the quarter. In the reported quarter, non-GAAP SG&A reduced to 21.9% from 23.7% in the year-ago quarter.
Financial Position
As of Dec 29, 2012, cash and cash equivalents and short-term investments were $55.5 million compared with $76.1 million as of Dec 31, 2011. Shareholders’ equity at year-end 2012 was $212.2 million compared with $268.4 million in the prior-year period.
Outlook
CRA international aims to do away with the underperforming assets from its portfolio to better focus on service portfolio and allocate its resources on core areas to enhance business profitability and is bullish about overall growth in 2013. Based on its restructuring initiatives, CRA International aims to achieve profitable growth both organically and through strategic hires.
However, the company operates in an intensely competitive landscape that includes big players such as Corporate Executive Board Co (CEB - Snapshot Report) and Navigant Consulting Inc (NCI - Analyst Report). CRA International currently has a Zacks Rank #1 (Strong Buy). One of its competitors, Towers Watson & Co (TW - Snapshot Report) also carries a Zacks Rank #1 (Strong Buy).
Get the full Analyst Report on NCI - FREE
Get the full Analyst Report on CRAI - FREE
Get the full Snapshot Report on TW - FREE
Get the full Snapshot Report on CEB - FREE